In the midst of the opioid epidemic, communities across the country face increased demands for prevention and substance use services.
The CDC reports that:
- Young adult’s heroin use more than doubled in the past decade.
- More than 90 percent of people who use heroin also use at least one other drug.
- 45 percent of people who use heroin are also addicted to prescription opioid painkillers.
- Prescription opioid drug overdoses increased threefold in three years.
To combat this crisis, behavioral health organizations are increasingly utilizing evidence-based practices such as medication assisted treatment (MAT).
Medications such as buprenorphine and methadone consistently prove effective in treating opioid use disorder. In recent years, extended-release naltrexone has also been approved for the treatment of opioid dependence and shown evidence of effectiveness. The use of naloxone has also become an increasingly important component of local efforts to combat opioid overdose and death. Increasing access to these and other medications and services is critical to stemming the tide of this current epidemic.
Whether you’ve been utilizing MAT for years or you’re just beginning to look at the practice, the National Council has compiled this page as a trusted resource for your organization.
MAT for Opioid Use Disorders Video Interview Series
Click on a video below to watch.
Want the evidence base for MAT? Check out this interactive presentation by Arthur Robin Williams, M.D.
- Webinar: Addressing SUDs in the Primary Care setting. (Click to hear the recording)
- MAT Implementation Checklist
- Expanding the Use of Medications to treat individuals with Substance Use Disorder
- Experts talk MAT in eSolutions Newsletter
Click here to view more resources
Opioid Dependence 101 and MAT
Making the Case: How MAT Improves Mental Health Care
MAT Roundtable: Lessons Learned from CBHOs Implementing MAT for Opioid Use Dependence
Medication-Assisted Treatment: Lessons Learned from the Field